| Net Cash Provided by (Used in) Operating Activities |
$32,000 |
USD |
-300% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$672,000 |
USD |
19% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$738,000 |
USD |
-1.6% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$26,227,000 |
USD |
-3% |
Q4 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$2,000 |
USD |
100% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
$2,167,000 |
USD |
-4.3% |
Q2 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
-100% |
Q3 2024 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$210,000 |
USD |
-44% |
Q4 2025 |
Q2 2026 |
| Property, Plant and Equipment, Gross |
$5,807,000 |
USD |
0.14% |
Q2 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$393,000 |
USD |
487% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$0 |
USD |
-100% |
Q2 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$833,000 |
USD |
1.3% |
Q4 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,549,000 |
USD |
-29% |
Q2 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$0 |
USD |
-100% |
Q4 2025 |
Q2 2026 |
| Interest Expense |
$3,000 |
USD |
0% |
Q1 2024 |
Q3 2024 |